| Net Cash Provided by (Used in) Operating Activities |
$366,922 |
USD |
19% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$6,998,500 |
USD |
1389% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$0 |
USD |
-100% |
Q3 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
400,000,000 |
shares |
0% |
Q3 2025 |
Q1 2026 |
| Common Stock, Shares, Issued |
120,370,467 |
shares |
116% |
Q3 2025 |
Q1 2026 |
| Common Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
0% |
Q3 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$6,631,578 |
USD |
18313% |
Q3 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$9,414,926 |
USD |
3266% |
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$6,764,000 |
USD |
21% |
Q2 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$6,764,000 |
USD |
21% |
Q2 2025 |
FY 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$3,981,333 |
USD |
-41% |
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$5,698,000 |
USD |
8.9% |
Q2 2025 |
FY 2025 |
| Additional Paid in Capital |
$44,300,245 |
USD |
33% |
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q2 2025 |
FY 2025 |
| Interest Expense |
$139,827 |
USD |
-59% |
Q3 2025 |
Q1 2026 |